Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 5Lung Neoplasms 3Anxiety Disorders 3Solitary Pulmonary Nodule 2Paresthesia 2Multiple Pulmonary Nodules 2Hypesthesia 2Dyspnea 2Depression 2Brain Neoplasms 2Surgical Wound Infection 1Skin Neoplasms 1Radiation Injuries 1Pulmonary Atelectasis 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Prostatic Diseases 1Postoperative Complications 1Pain 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia 1Laparotomy 1Inflammatory Bowel Diseases 1Hypoxia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Oxygen × Clear all
NCT01799161 2014-11-17

Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer

University of Miami

Phase 1 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡